Mounjaro 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9R3C
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,180
Award facts
- Contract value 100% obligated
- $12,179.67 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,179.67 to Amerisourcebergen Drug Corp for the supply of Mounjaro 2.5 mg/0.5 mL pen injections on January 23, 2026, with a completion date of January 26, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used in military and federal healthcare systems, reflecting the Defense Logistics Agency's ongoing need to supply pharmaceutical products to support military treatment facilities and veterans' healthcare programs.
This delivery order falls under Amerisourcebergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as Amerisourcebergen), is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement. The company's role as a prime vendor under this comprehensive global pharmaceutical support vehicle enables it to supply a broad range of specialty medications, brand-name and generic drugs, vaccines, and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.
Quick answers
Who was awarded contract SPE2DR26F9R3C?
SPE2DR26F9R3C was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26F9R3C worth?
The government has obligated $12,180 on SPE2DR26F9R3C.
Is contract SPE2DR26F9R3C an order under another contract?
Yes. SPE2DR26F9R3C is a delivery order under SPE2DR25D3020, an indefinite delivery contract.
Was contract SPE2DR26F9R3C competed?
The extent of competition for SPE2DR26F9R3C was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award